Nonscarring Alopecias: Clues & Treatment Options
Dr. Victoria Barbosa, associate professor of medicine at the University of Chicago Pritzker School of Medicine, spoke with Next Steps in Derm, in partnership with Skin of Color Update, about the two categories of nonscarring alopecias. Hear why Dr. Barbosa says clinicians need to give ample time to counseling patients about behavioral changes to prevent progression of hair loss. Learn about recen …
Dr. Victoria Barbosa, associate professor of medicine at the University of Chicago Pritzker School of Medicine, spoke with Next Steps in Derm, in partnership with Skin of Color Update, about the two categories of nonscarring alopecias. Hear why Dr. Barbosa says clinicians need to give ample time to counseling patients about behavioral changes to prevent progression of hair loss. Learn about recen … Continue reading "Nonscarring Alopecias: Clues & Treatment Options"
Alopecia areata (AA) is a nonscarring alopecia driven by autoreactive cytotoxic CD8 T cells against hair follicle antigens. With an unpredictable clinical course, which can include alopecia totalis and universalis, AA can be debilitating to patients’ quality of life. Historically, glucocorticosteroids, cyclosporine, methotrexate, and azathioprine were used off-label for non-targeted immunosuppre … 
INTRODUCTION
Alopecia areata (AA) is a condition characterized by nonscarring hair loss. Cases of alopecia areata are most commonly seen in patients under age 30 and are frequently idiopathic. In this report, we discuss a woman in her 50s who developed AA shortly after receiving the Tdap vaccine and after one year of guselkumab therapy.
CASE
A woman in her 50s with history of psor …